Jubilant Pharmova Limited Share Price & Technical Analysis
JUBLPHARMA · ₹1,007 (+0.09%)
Healthcare / Drug Manufacturers - Specialty & Generic
₹1,007
+0.09%
Jubilant Pharmova Limited operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally. It operates through six segments: Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research Development and Manufacturing Organisation; and Proprietary Novel Drugs. The Radiopharma segment of…
Price chart
Seasonality
May has 4 positive and 1 negative years (last 5 years shown)
8% return in May, 13% avg return in past 3 year May month.
2% return in 2026, 40% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -8% | -10% | -1% | 13% | 8% | – | – | – | – | – | – | – | 2% |
| 25 | -12% | -5% | -1% | 1% | 31% | 3% | -1% | -13% | 6% | 2% | -1% | -1% | 7% |
| 24 | 0% | -1% | 0% | 18% | 2% | 6% | 5% | 18% | 25% | 6% | 0% | -10% | 68% |
| 23 | -7% | -14% | -8% | 11% | 6% | 20% | -6% | 24% | -8% | -15% | 14% | 26% | 45% |
| 22 | -13% | -24% | -2% | 20% | -19% | -12% | 4% | -3% | -4% | 9% | 6% | -4% | -41% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Emerging · Strong
Jubilant Pharmova Limited operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally. It operates through six segments: Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research Development and Manufacturing Organisation; and Proprietary Novel Drugs. The Radiopharma segment offers radiopharmaceuticals products, which are used in the diagnosis and treatment of various diseases, including pulmonary embolism, cancer, coronary artery disease, and others. Its Allergy Immunotherapy segment provides specialised diagnostic devices for skin testing, as well as venom and allergy immunotherapy products. The Contract Development and Manufacturing Organisation - Sterile Injectables segment offers contract manufacturing services for sterile fill and finish injectables, liquids, ointments, creams, and ampoules. Its Generics segment engages in the development, manufacturing, distribution, sale, and marketing of generic formulations for therapeutic areas comprising cardiovascular system, central nervous system, gastrointestinal, antibiotics, and multispecialty. The Contract Research Development and Manufacturing Organisation segment offers drug discovery services and active pharmaceutical ingredients. The Proprietary Novel Drugs segment provides patient-focused biopharmaceutical services to address unmet medical needs in oncology and autoimmune diseases. The company serves pharmaceutical, biotech, group purchasing organisations, allergists, and hospitals sectors. It sells its products through a network of dealers and distributors. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021. The company was incorporated in 1978 and is based in Noida, India.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹156.50B
P/E ratio
36.27
52W high
₹1,248
52W low
₹786.1
Volume
3,73,009
Beta
0.51
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹2,260
Frequently asked questions
- What is Jubilant Pharmova Limited share price today?
- Jubilant Pharmova Limited (JUBLPHARMA) last traded around ₹1,007 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does JUBLPHARMA have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for JUBLPHARMA. Download the app for real-time alerts.
- How can I analyze Jubilant Pharmova Limited stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.